Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of General Surgery
>
2001
>
10
>
2
Volume:
10
Issue:
2
1. Hepatic artery and portal vein dual perfusion chemotherapy combined with intratumoral injection of lipiodol-ethanol for unresec-table primary hepatic carcinoma
Page:111—114
2. Radiofrequency ablation for primary and metastatic hepatic cancer
Page:106—110
3. Percutaneous radiofrequency ablation of hepatic malignancies guided by ultrasonography
Page:102—105
4. Influential factors on treatment effect of primary hepatic cancer and the countermeasure
Page:97—98
5. Heptocellular carcinoma with serum AFP level in 21μg/L to 200 μg/L
Page:176—178
6. Mechnisms of ischemia/reperfusion injury in transplanted liver
Page:173—175
7. Diagnosis and treatment of simple macromastia and complex macromastia
Page:169—172
8. Management of Budd-Chiari syndrome complicated with abdominal compartment syndrome
Page:166—168
9. Anticipated value of ICGR15 and OGTT for hepatic reserving function in patients with primary hepatic cancer
Page:162—165
10. Rare type of hepatic benign tumor and tumor-like lesions
Page:159—161
11. Changes of hemodynamics during heterotopic partial liver transplantation in pigs
Page:155—158
12. Diagnosis and treatment of acute rejection of liver transplantation (a report of 2 cases)
Page:152—154
13. Inferior vena cava stenosis after orthotopic liver transplantation: diagnosis and treatment
Page:149—151
14. Diagnosis and treatment of post-orthotopic liver transplantation complications (a report of 7 cases)
Page:146—148
15. Surgical complications of orthotopic liver transplantation
Page:142—145
16. Effect of γ-interferon on the expresson of Fas, Bcl-2 on Hep-G2 hepatocellular carcinoma cells
Page:139—141
17. Effects of arsenic trioxide on hepatoma cell line HLE
Page:134—138
18. The expression and clinical significance of vascular endothelial growth factor in primary hepatocellular carcinoma
Page:130—133
19. Semi-quantitative analysis of MCT1 and MCT2 genes mRNA expression in human hepatocellular carcinoma
Page:126—129
20. Obstructive jaundice caused by hepatocellular carcinoma(a report of 16 cases)
Page:123—125
21. Palliative resection of advanced primary hepatocellular carcinoma
Page:120—122
22. HAI and/or PVI after radical resection of primary hepatic carcinoma for preventing tumor recurrence
Page:117—119
23. Resection of segment VIII of liver after cryotherapy for hepatocarcinoma
Page:115—116